Story thread · 3 reports / 2 sources
Novo Nordisk (NVO)’s Pediatric Obesity Opportunity Faces a Bigger Test
finance.yahoo.com · 2d
First report: Can Oral Wegovy Help Novo Nordisk Capture China’s $4.46 Billion GLP-1 Opportunity? — finance.yahoo.com, 5d
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.